dm+d

85272000

Articles

Managing peripheral oedema caused by calcium channel blockers

26 September 2022All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Safety in Lactation: Drugs for hypertension

23 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Many of the drugs covered by…
Search Articles

Medicine Compliance Aid Stability

Coracten SRUCB Pharma Ltd

UCB Pharma Ltd
Coracten SR
Capsules m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Valni XLZentiva

Zentiva
Valni XL
Tablets m/r 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Fortipine LAADVANZ pharma

ADVANZ pharma
Fortipine LA
Tablets m/r 40mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Nifedipress MRDexcel Pharma Ltd

Dexcel Pharma Ltd
Nifedipress MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Coracten XLUCB Pharma Ltd

UCB Pharma Ltd
Coracten XL
Capsules 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from light.
10 October 2022

Adipine MRThornton & Ross Ltd

Thornton & Ross Ltd
Adipine MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Tensipine MRGenus Pharmaceuticals

Genus Pharmaceuticals
Tensipine MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Adalat LABayer plc

Bayer plc
Adalat LA
Tablets m/r 20mg, 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Adipine XLChiesi Ltd

Chiesi Ltd
Adipine XL
Tablets m/r 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022

Lactation Safety Information

Yes
-
Moderate published evidence of safety
Extensive experience of safe use in breastfeeding
Small amounts in breast milk
No adverse effects reported in breastfed infants
Used in infants >1 month
Preferred choice during breastfeeding for treating Raynaud’s syndrome
16 January 2017